Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-Tα1 and Adefovir for HBeAg-Positive Chronic Hepatitis B
NCT02366208Phase 2Completed
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- May 2011
- Primary completion
- Jun 2013
- Modality
- Peptides, Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of polyethylene glycol thymosin alpha1 in Chronic Hepatitis B (CHB), sponsored by Hansoh Pharmaceutical Group. Started May 2011; status: completed.
02
Drugs
polyethylene glycol thymosin alpha1
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02366208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02366208.